G1 Therapeutics, Inc. - SEC Filings

Search Ctrl + K

G1 Therapeutics, Inc.

Pharmaceutical Preparations

NASDAQ.GTHX

700 Park Offices Drive, Suite 200, Research Triangle Park, NC, 27709

© 2023 Gheko, Inc. Terms of Service Privacy Policy Browse Companies

News

Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modifications To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits

Results Of Operations And Financial Condition

Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits

Regulation Fd Disclosure

Submission Of Matters To A Vote Of Security Holders

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits

Other

Certification And Notice Of Termination Of Registration Under Section 12(g) Or Suspension Of Duty To File Reports.

Amended Solicitation/recommendation Statement Under Section 14(d)(4).

Amended Solicitation/recommendation Statement Under Section 14(d)(4).

Amended Solicitation/recommendation Statement Under Section 14(d)(4).

Solicitation/recommendation Statement Under Section 14(d)(4) Of The Exchange Act.

Written Communication Relating To A Third Party Tender Offer.

Written Communication Relating To A Third Party Tender Offer.

Ownership

Murdock Terry L

Thomas Monica R.

Bailey John E. (jack) Jr.

Proxies

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

Preliminary Proxy Statement Not Yet Definitive.

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

Financials

Quarterly Filing

Quarterly Filing

Fiscal Year 2024

Quarterly Filing

Quarterly Filing

Quarterly Filing

Fiscal Year 2022

Prospectuses and Registrations

Post-effective Amendment To An S-8 Filing.

Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.

Post-effective Amendment To An S-8 Filing.

Post-effective Amendment To An S-8 Filing.

Amended Tender Offer Statement By Third Party.

Post-effective Amendment To An S-8 Filing.

Post-effective Amendment To An S-8 Filing.